Pharma News
-
Sun Pharma acquires Japan's Pola Pharma
Pharma | News | 0 Comment | 29 Nov, 2018
Sun Pharmaceutical, recently announced that it has entered into a definitive agreement to acquire Pola Pharma Inc. (“Pola Pharma”), a Japanese pharmaceutical company engaged in ...Read more
-
Ono files for approval of ONO-7643 in Japan
Pharma | News | 0 Comment | 28 Nov, 2018
Ono Pharmaceutical announced today that ONO has submitted in Japan an application for manufacturing and marketing approval of anamorelin hydrochloride (ONO-7643) (“Anamorelin&rd...Read more
-
Daiichi Sankyo launches Trastuzumab Biosimilar in Japan
Pharma | News | 0 Comment | 28 Nov, 2018
Daiichi Sankyo Company, Limited has launched the antitumor agent trastuzumab Biosimilar for intravenous drip infusions 60 mg and 150 mg “Daiichi Sankyo” in Japan. The product i...Read more
-
Pharma | News | 0 Comment | 28 Nov, 2018
Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific Officer, effective December 10, 2018. Dr. Dhanak will succeed ...Read more
-
ST Pharm receives recognition for global API manufacturing
Pharma | News | 0 Comment | 28 Nov, 2018
South Korea based ST Pharm Co Ltd was recognized with the Global API Manufacturing (Oligonucleotide) Growth Excellence Leadership award at the annual Frost & Sullivan Asia-Pacific Best ...Read more
-
CURE Pharma gets USDEA nod to develop cannabinoid-based products
Pharma | News | 0 Comment | 28 Nov, 2018
CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug Enforcement Administration (DEA) as a manufacturer authorized to handl...Read more
-
Aspen launches novel HIV drug combination
Pharma | News | 0 Comment | 28 Nov, 2018
Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of Emdolten, a Dolutegravir-based triple combination anti-retroviral (ARV...Read more
-
Eisai to present new research on Eribulin at SABC Symposium
Pharma | News | 0 Comment | 27 Nov, 2018
Eisai Co., Ltd. has announced that the latest information on its in-house discovered and developed anticancer agent eribulin mesylate (halichondrin class microtubule dynamics inhibitor, pro...Read more
-
ROHTO Pharma launches cooling Eye Drops range in India
Pharma | News | 0 Comment | 27 Nov, 2018
The red, irritated eye because of pollution, the itchy eye after a mid-day hike; even the dry eye because of screen time. All of these can make the warm weather months a less than eye-openi...Read more
-
Chi-Med announces commercial launch of Elunate
Pharma | News | 0 Comment | 27 Nov, 2018
Hutchison China MediTech Limited (Chi-Med) has announced the first commercial launch of fruquintinib capsules (Elunate) with the initiation of product sales in China. Elunate is for the tre...Read more
-
Admedus appoints Matthew McDonnell as interim CFO
Pharma | News | 0 Comment | 26 Nov, 2018
Medical technology company Admedus has appointed former KPMG partner Matthew McDonnell as its interim CFO. With over 24 years at KPMG, including 10 years as a partner, Mr McDonnell br...Read more
-
Santhera to acquire exclusive sub-license of Vamorolone
Pharma | News | 0 Comment | 26 Nov, 2018
Santhera Pharmaceuticals which is Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare and other diseases and Idorsia Ltd...Read more
-
OIC Medicines Authorities plan to achieve self-reliance in medicines, vaccines
Pharma | News | 0 Comment | 26 Nov, 2018
The heads of National Medicines Authorities (NMRA) from the Organization of Islamic Cooperation (OIC) announced the Jakarta Declaration during their first meeting, held here November 21-22....Read more
-
Eisai to present latest data on Perampanel at AES annual meeting
Pharma | News | 0 Comment | 23 Nov, 2018
Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 72nd American Epilepsy Society Annual Meeting (AES...Read more
-
Takeda receives clearance from EC for proposed acquisition of Shire
Pharma | News | 0 Comment | 22 Nov, 2018
Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire announced on May 8, 2018. The EC’s approval is conditional on T...Read more
-
Mylan recalls batches of blood-pressure drug containing valsartan
Pharma | News | 0 Comment | 22 Nov, 2018
Singapore - Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing ...Read more
-
Phebra announces new UK subsidiary company
Pharma | News | 0 Comment | 21 Nov, 2018
Leading Australian pharmaceutical firm Phebra has announced the expansion of its international operations, with the establishment of new wholly-owned subsidiary company in the United Kingdo...Read more
-
Compai, Pharmacosmos partner to launch MonoFer in Malaysia
Pharma | News | 0 Comment | 21 Nov, 2018
Singapore - Compai Pharma (a Malaysia based medical and pharmaceutical company) and Pharmacosmos (a family-owned Danish pharmaceutical company headquartered in Denmark) announce their partn...Read more
